CP3 Director Dr. Walid Gellad spoke with Trib Live about recent drug pricing changes, why the ten drugs were chosen for negotiation, and how that might affect patients. “Medications have become much more expensive. It’s not necessarily to do with the inflation that we are all dealing with — the prices have gone up and up and up and up, and there’s been nothing to stop them from going up,” he said. “Because of the donut hole and the lack of any cap, patients have been exposed to that. It’s really just decades of increasing pricing of pharmaceuticals. This is a long-standing problem.”